The MicroArray Quality Control (MAQC) consortium has evaluated methods for making clinically useful predictions from large-scale gene expression data. Existing clinical predictors have well-known ...
Affymetrix Inc. has announced the launch of Affymetrix University, a series of hands-on data analysis training courses that will be held in various locations throughout Europe and North America.
Microarray analysis is a rapidly evolving technology that has yielded enormous quantities of data, which are not yet fully understood. Leading scientific journals require investigators carrying out ...
Participants learn how to prepare high quality fluorescently labeled gDNA then set up, hybridize and wash microarrays ready for analysis. The innovative coursework provides improved methods for ...
The objective of many high-dimensional microarray and RNA-seq studies is to develop a classifier of cancer patients based on characteristics of their disease. The germinal center B-cell (GCB) ...
Whole-genome microarray gene expression profiling has rapidly become the gold standard platform for retrospective prognostic and predictive gene discovery in human cancers, but currently depends on ...
October 19, 2011 (Montreal, Quebec) — Investigators at the University of Pittsburgh have developed a comparative genome hybridization (CGH) microarray that offers significantly superior resolution and ...
Reviewed by Dr. Tomislav Meštrović, MD, Ph.D. The microarray is a very recent development in the field of biotechnology. Scientists are now able to understand the gene functions of any organism by ...
Current staging methods are inadequate for predicting the outcome of treatment of non–small-cell lung cancer (NSCLC). We developed a five-gene signature that is closely associated with survival of ...
Spectrum Solutions’ offerings enhanced by including CLIA/CAP laboratory testing, custom assay development, and manufacturing of industry-leading microarray chip technology. These valuable assets, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results